CA
ABBV icon

Cynosure Advisors’s AbbVie ABBV Stock Holding History

Cynosure Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-10,852
Closed -$1M – 15
2018
Q2 		$1M Hold
10,852
– – 0.27% 44
2018
Q1 		$1.03M Sell
10,852
-1,555
-13% -$171K 0.26% 40
2017
Q4 		$1.2M Buy
+12,407
New +$1.17M 0.28% 33

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cynosure Advisors's ABBV Position: Q3 2018 in Review

Cynosure Advisors sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 10,852 shares — an estimated $1M sold.

Cynosure Advisors first reported a position in ABBV in Q4 2017 and held it in 3 quarters. The position peaked at $1.2M in Q4 2017. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

  • Cynosure Advisors reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
  • Cynosure Advisors sold 10,852 AbbVie shares in Q3 2018, an estimated $1M.
  • Cynosure Advisors first reported a position in AbbVie in Q4 2017 and held it in 3 quarters.
  • Cynosure Advisors's AbbVie position peaked at $1.2M in Q4 2017.
  • 1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Cynosure Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.